Themis Medicare's Q1 FY 2026-27 Quarterly Results

Result Summary

• Themis Medicare Ltd reported a 9.7% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2026-27). On a year-on-year (YoY) basis, it witnessed a decline of 10.9%.
• Its expenses for the quarter were up by 85.6% QoQ and 28.6% YoY.
• The net profit increased 176.8% QoQ and decreased 273.1% YoY.
• The earnings per share (EPS) of Themis Medicare Ltd stood at 2.67 during Q1 FY 2026-27.

Financial Statments for Q1 FY 2026-27

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Themis Medicare Ltd is a pharmaceutical company that operates in the healthcare industry. The company is engaged in the development, manufacturing, and marketing of a wide range of pharmaceutical and healthcare products. These products primarily cater to therapeutic segments such as anti-infectives, anti-malaria, and pain management, among others. Themis Medicare is known for its innovative approach and commitment to delivering quality healthcare solutions. However, specific details regarding recent major developments or strategic initiatives undertaken by the company are not available in the provided data.

Revenue

In the first quarter of fiscal year 2027, Themis Medicare Ltd reported a total income of ₹87.95 crores. This marks an increase of 9.7% compared to the previous quarter (Q4 FY26), where the total income was ₹80.20 crores. However, when compared to the same quarter in the previous year (Q1 FY26), there is a decline in total income by 10.9%, as the income then stood at ₹98.75 crores. This quarterly growth and annual decline in total income highlight the company's varying revenue performance over the periods in question.

Profitability

The company's profitability metrics for Q1 FY27 display significant changes. The profit before tax (PBT) for this quarter was ₹36.01 crores, showing a dramatic increase of 1590.6% from the previous quarter's PBT of ₹2.13 crores. Year-over-year, there is a substantial turnaround, as the company recorded a loss before tax of ₹13.93 crores in Q1 FY26. After accounting for taxes, the profit after tax (PAT) for Q1 FY27 was ₹24.61 crores, up 176.8% from ₹8.89 crores in Q4 FY26. Comparatively, the PAT improved significantly year-over-year, considering a loss of ₹14.22 crores was reported in Q1 FY26. Earnings per share (EPS) followed a similar trend, increasing to ₹2.67 in Q1 FY27 from ₹0.96 in Q4 FY26, and recovering from a negative EPS of -₹1.54 in Q1 FY26.

Operating Metrics

Themis Medicare Ltd's operating expenses in Q1 FY27 amounted to ₹144.90 crores, reflecting a substantial increase of 85.6% from Q4 FY26's total expenses of ₹78.07 crores. Year-over-year, the expenses rose by 28.6% from ₹112.68 crores in Q1 FY26. The significant rise in expenses quarter-over-quarter and year-over-year is noteworthy. The tax expense also saw a dramatic increase, with Q1 FY27 recording ₹13.99 crores, compared to only ₹0.17 crores in Q4 FY26 and ₹0.16 crores in Q1 FY26, indicating a notable change in the company's tax obligations over the periods.